These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 1884730)
1. Debrisoquine oxidation polymorphism in a Tasmanian population. Veronese ME; McLean S Eur J Clin Pharmacol; 1991; 40(5):529-32. PubMed ID: 1884730 [TBL] [Abstract][Full Text] [Related]
2. Evidence for the polymorphic oxidation of debrisoquine in the Thai population. Wanwimolruk S; Patamasucon P; Lee EJ Br J Clin Pharmacol; 1990 Feb; 29(2):244-7. PubMed ID: 2306417 [TBL] [Abstract][Full Text] [Related]
3. Debrisoquine oxidation in a Finnish population: the effect of oral contraceptives on the metabolic ratio. Kallio J; Lindberg R; Huupponen R; Iisalo E Br J Clin Pharmacol; 1988 Dec; 26(6):791-5. PubMed ID: 3242585 [TBL] [Abstract][Full Text] [Related]
4. Polymorphism of the 4-hydroxylation of debrisoquine in the San Bushmen of southern Africa. Sommers DK; Moncrieff J; Avenant J Hum Toxicol; 1988 May; 7(3):273-6. PubMed ID: 3391625 [TBL] [Abstract][Full Text] [Related]
5. Debrisoquine oxidation in an Australian population. Peart GF; Boutagy J; Shenfield GM Br J Clin Pharmacol; 1986 May; 21(5):465-71. PubMed ID: 3718805 [TBL] [Abstract][Full Text] [Related]
6. [Study on the frequency distribution of debrisoquine hydroxylation deficiency in Chinese healthy Zang and Wei volunteers]. Kuang TY; Liao XM; Wang KY; Zhang Y; Lou YQ Yao Xue Xue Bao; 1991; 26(4):250-4. PubMed ID: 1957669 [TBL] [Abstract][Full Text] [Related]
7. A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population. Evans DA; Mahgoub A; Sloan TP; Idle JR; Smith RL J Med Genet; 1980 Apr; 17(2):102-5. PubMed ID: 7381862 [TBL] [Abstract][Full Text] [Related]
8. Metoprolol alpha-hydroxylation polymorphism in the San Bushmen of southern Africa. Sommers DK; Moncrieff J; Avenant J Hum Toxicol; 1989 Jan; 8(1):39-43. PubMed ID: 2714809 [TBL] [Abstract][Full Text] [Related]
9. Polymorphism of debrisoquine 4-hydroxylation and family studies of poor metabolizers in Chinese population. Du YL; Lou YQ Zhongguo Yao Li Xue Bao; 1990 Jan; 11(1):7-10. PubMed ID: 2403020 [TBL] [Abstract][Full Text] [Related]
10. The metabolism of mexiletine in relation to the debrisoquine/sparteine-type polymorphism of drug oxidation. Broly F; Vandamme N; Libersa C; Lhermitte M Br J Clin Pharmacol; 1991 Oct; 32(4):459-66. PubMed ID: 1958440 [TBL] [Abstract][Full Text] [Related]
11. Relation between debrisoquine oxidation phenotype and morphological, biological, and pathological variables in a large population. Vincent-Viry M; Muller J; Fournier B; Galteau MM; Siest G Clin Chem; 1991 Mar; 37(3):327-32. PubMed ID: 2004438 [TBL] [Abstract][Full Text] [Related]